NASDAQ:BLAC Bellevue Life Sciences Acquisition (BLAC) Stock Price, News & Analysis → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free BLAC Stock Alerts $10.82 +0.11 (+1.03%) (As of 05/8/2024 ET) Add Compare Share Share Today's Range$10.72▼$11.4450-Day Range$10.58▼$10.8352-Week Range$10.15▼$11.44Volume3,621 shsAverage Volume41,070 shsMarket Capitalization$60.81 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial Media Get Bellevue Life Sciences Acquisition alerts: Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About Bellevue Life Sciences AcquisitionBellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.Read More BLAC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BLAC Stock News HeadlinesApril 21, 2023 | wsj.comBellevue Life Sciences Acquisition Corp.April 18, 2023 | seekingalpha.comBLACW Bellevue Life Sciences Acquisition Corp. WT EXP 020928See More Headlines Receive BLAC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:BLAC CUSIPN/A CIK1840425 Webwww.bellevuespac.com Phone425-635-7700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares5,620,000Free Float4,740,000Market Cap$60.81 million OptionableNot Optionable Beta-0.03 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Kuk Hyoun Hwang (Age 47)CEO & Director Mr. David Jin Yoo (Age 50)Chief Financial Officer Key CompetitorsCorner Growth Acquisition Corp. 2NASDAQ:TRONCactus Acquisition Corp. 1NASDAQ:CCTSInception Growth AcquisitionNASDAQ:IGTAJVSPAC AcquisitionNASDAQ:JVSAHHG CapitalNASDAQ:HHGCView All CompetitorsInstitutional OwnershipWealthspring Capital LLCSold 32,684 shares on 4/18/2024Ownership: 0.606%Karpus Management Inc.Sold 16,600 shares on 2/13/2024Ownership: 0.956%Condor Capital ManagementBought 11,570 shares on 2/12/2024Ownership: 0.128%View All Institutional Transactions BLAC Stock Analysis - Frequently Asked Questions How have BLAC shares performed in 2024? Bellevue Life Sciences Acquisition's stock was trading at $10.50 at the beginning of 2024. Since then, BLAC shares have increased by 3.0% and is now trading at $10.82. View the best growth stocks for 2024 here. Are investors shorting Bellevue Life Sciences Acquisition? Bellevue Life Sciences Acquisition saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 2,200 shares, an increase of 46.7% from the March 31st total of 1,500 shares. Based on an average daily trading volume, of 23,800 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.1% of the company's shares are short sold. View Bellevue Life Sciences Acquisition's Short Interest. Who are Bellevue Life Sciences Acquisition's major shareholders? Bellevue Life Sciences Acquisition's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Wealthspring Capital LLC (0.61%). How do I buy shares of Bellevue Life Sciences Acquisition? Shares of BLAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BLAC) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDems have chosen Biden replacement?Paradigm PressThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.